STEM CELL, absolutely. We're on the same wave length, That's why i cited Dr. Scarlett's resume as just what, imo we need to truly move forward assuming our science is confirmed and commercial.I think that last caveat is what was at work in chosing Rabin.
It's very difficult for me to understand the ACTC's Board's thinking in appointing Rabin ceo for a company that was going it alone to commercialization years down the line.
I'm guessing, in their thinking, that they must see ACTC success around the corner, the company eventually being absorbed one way or another and Rabin replaced. When Rabin was appointed, we had not even had any initial data from the human clinical trials, positive or negative, so, in one sense, the company was still on a hope and a prayer and the board was paying back an insider who could do the immediate things that needed to be done given his familiarity with what had transpired with Dr. Caldwell.
Why would someone of a Dr. Scarlett pedigree even consider a job with a company at that tenuous stage in it's development?
Moving on, now once you have the product, that's no guarantee you're going anywhere as a successful company without the management to make it happen and it's sure difficult for many of us on this board, apparently, to see that with continuing company success and growth, that Rabin is the right person for the job for a multitude of reasons.
The stark reality, I guess, is it really takes a company with much proven promise and success to attract top tier folks of Dr. Scarlett's pedigree.
As I try to put my arms around the decision to appt. Rabin, I'm reminded of a typical company or academic scenario, where there's a search (questionable in the case of ACTC, imo....at best just feelers) where there's a bunch of outside candidates and an internal candidate. Guess who often gets the position?
I'd be interested in your or anyone's thoughts on my premises and how the future of ACTC will unfold, or be forced to unfold given things like funding for phase III trials and salaries, etc.
many thanks.
News 
Market Data 
Discover 
AI
